US · Healthcare · Health Information Services
EPS came in at 0.04 against a street estimate of 0.13 — a miss of 69.2%.
Analysts rate Veradigm Inc. a buy (1 buy, 2 hold, 0 sell out of 3) with an average price target of $6.50.
| Fund | Stake |
|---|---|
| FNY Investment Advisers, LLC | 0.01% |
| Huntington National Bank | 0.00% |
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Veradigm Inc. — free to start.
Google PlayApp StoreData updated 2026-08-05.